After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization